Sign up
Pharma Capital

OptiBiotix Health chief outlines critical new SlimBiome distribution deal

OptiBiotix Health PLC (LON:OPTI) chief executive Stephen O'Hara discusses an exclusive agreement they've signed with DKSH International to distribute its SlimBiome weight management ingredient in Italy and Spain.

To maintain its market exclusivity, the multi-billion-dollar Swiss firm will have to meet certain sales targets, which Opti believes will maximise the financial return for both parties.

 

View full OPTI profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.